SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015)
SELLAS Life Sciences (SLS) reported Amortization - Intangibles of $442000.0 for Q2 2015, up 351.02% year-over-year from $98000.0 in Q2 2014, and up 202.74% quarter-over-quarter from $146000.0 in Q1 2015.
SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has 3 years of Amortization - Intangibles data on file, last reported at $442000.0 in Q2 2015.
- Amortization - Intangibles for Q2 2015 came in at $442000.0, up 351.02% year-over-year; the trailing twelve-month figure through Jun 2015 was $756000.0 (up 225.86% YoY), and the FY2017 annual result was $1.9 million, changed N/A from the prior year.
- Amortization - Intangibles advanced to $442000.0 in Q2 2015 per SLS's latest filing, from $146000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $442000.0 in Q2 2015 and troughed at $43000.0 in Q3 2013.
- A 3-year average of $148333.3 and a median of $94500.0 in 2014 frame the typical range for Amortization - Intangibles.
- On a YoY basis, Amortization - Intangibles climbed as much as 351.02% in 2015 and fell as far as 60.44% in 2015.
- A 3-year view of Amortization - Intangibles shows it stood at $43000.0 in 2013, then soared by 62.79% to $70000.0 in 2014, then surged by 531.43% to $442000.0 in 2015.
- Business Quant data shows SLS's Amortization - Intangibles at $442000.0 in Q2 2015, $146000.0 in Q1 2015, and $70000.0 in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 442,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Sep 30, 2014 | 70,000.00 |
| Jun 30, 2014 | 98,000.00 |
| Mar 31, 2014 | 91,000.00 |
| Sep 30, 2013 | 43,000.00 |